Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |